Phillips CPAP Stockholders Were Tipped Off About CPAP Failures More Than A Month Before Millions of Users

Phillips failed to warn their customer for forty-five days after they warned stockholders about their machine's malfunctions.

Tuesday, September 14, 2021 - Royal Phillips waiting an unacceptable amount of time before informing its customers of the defects of their CPAP and other sleep apnea devices. The Phillips CPAP recall did not occur for more than a month after making their shareholders aware of a life-threatening malfunction in their sleep apnea and ventilator devices. Records show that Royal Phillips informed their shareholders on April 26, 2021, of the defects and the likelihood of the 3.5 million Phillips CPAP machine unit recall. Phillips did not inform its customers until June 14, 2021, after waiting nearly two months and giving their shareholders time to bail out on their stock or cover their position should they desire to do so. For 45 days, Phillips sleep apnea patients inhaled toxic particles, chemicals, and gasses from the faulty PE-PUR foam that functioned to insulate the device, prevent vibration, and muffle the noise the mechanical device makes throughout the night.

Forty-five days is more than long enough for millions of trusting, unsuspecting users to inhale a level of carcinogens sufficient to produce Phillips CPAP cancer in the near or not distant future. Lung cancer can either spread quickly in about six months, in the case of small cell lung cancer, or can take years, sometimes more than a decade for the painful symptoms of lung pain, shortness of breath, and coughing blood to become disturbingly apparent. Royal Phillips has now begun to offer repair or replace solutions to the three million-plus CPAP customers affected by the June recall. The company will start repairing first-generation Phillips DreamStation devices sold in the United States.

If there is one thing that companies can learn to protect themselves from lawsuits is that it is not enough to own up to your product's defects only during stockholder meetings. A company also must inform existing customers of impending dangers that the product they purchased could present. Companies should be required to create and maintain a database of a purchaser's name, address, phone, and email address, plus the date of the purchase and the make and model of the device. A company can issue updates to their product instantly with a push of a button if this information is readily on hand, and establish a date to show when they took action to protect their customers. Also, there is no more likely prospect to make a future purchase than a current customer. When a company keeps accurate and complete product purchase records, there can be no excuse other than fraud and negligence when customers are not informed about the new-found dangers of a product they purchased. This is particularly true when the product is a drug that is consumed every day, or a device that is used all night. Phillips CPAP sleep apnea machine customers that have developed lung disease or suspect they have developed cancer are speaking with attorneys and considering filing a claim.

More Recent Philips CPAP Cancer Lawsuit News:

Lawyers for CPAP Cancer Lawsuits

We will represent all persons in involved in a BiPAP or CPAP cancer lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who developed cancer or another serious side effect as a result of using a Philips CPAP sleep apnea machine or ventilator in --or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Philips BiPAP cancer lawyers serving will contact you promptly to discuss your case.